Pfizer and BioNTech begin a study of an Omicron vaccine, with initial results expected in the first half of the year.


By BY BENJAMIN MUELLER from NYT Health https://ift.tt/3tZVqr6
https://ift.tt/3tZVqr6
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)